• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Microbiol . Development of a multi-species luciferase-based double-antigen ELISA for the detection of antibodies against influenza A virus H

tetano

Editor, Senior Moderator
J Clin Microbiol


. 2026 Aug 13:e0190725.
doi: 10.1128/jcm.01907-25. Online ahead of print.
Development of a multi-species luciferase-based double-antigen ELISA for the detection of antibodies against influenza A virus H5 clade 2.3.4.4b

Andrea Aebischer[SUP] 1 [/SUP], Anne Günther[SUP] 1 [/SUP], Ronja Piesche[SUP] 1 [/SUP], Kerstin Wernike[SUP] 1 [/SUP], Magdalena Murr[SUP] 2 [/SUP], Timm Harder[SUP] 1 [/SUP], Donata Hoffmann[SUP] 1 [/SUP], Christian Grund[SUP] 1 [/SUP], Beatriz Bellido Martín[SUP] 3 [/SUP], Ron Fouchier[SUP] 3 [/SUP], Katharina Daniel[SUP] 4 [/SUP], Leon Ullrich[SUP] 4 [/SUP], Rosanne Sprute[SUP] 4 5 6 [/SUP], Christoph Kreer[SUP] 4 7 [/SUP], Florian Klein[SUP] 4 6 [/SUP], Marco Roller[SUP] 8 [/SUP], Lukas Reese[SUP] 8 [/SUP], Josefine Wassermann[SUP] 9 [/SUP], Gereon Schares[SUP] 9 [/SUP], Maryna Kuryshko[SUP] 2 [/SUP], Elsayed M Abdelwhab[SUP] 2 [/SUP], Martin Beer[SUP] 1 [/SUP]


Affiliations
Abstract

The highly pathogenic avian influenza viruses of subtype H5N1 represent a major threat to animal and public health. The current panzootic with H5 clade 2.3.4.4b has caused numerous, widespread outbreaks in various domestic and wild avian species with high mortalities, massive losses, and a high frequency of spillover events to unexpected novel mammalian hosts, such as dairy cows. The global H5N1 situation raises serious concerns about zoonotic risks due to effective mammal-to-mammal transmission. Therefore, it is critical to increase surveillance intensity of a broadened species range, particularly at the human-animal interface. For this purpose, reliable and cost-effective serological tools that are easy to perform and suitable for high-throughput screening are critically needed. The newly developed double-antigen enzyme-linked immunosorbent assay format employing a luminescence-based detection technology has demonstrated compliance with such prerequisites. The assay allowed sensitive and specific detection of antibodies directed against H5 hemagglutinin of clade 2.3.4.4b in a wide range of birds and mammals, including humans. Furthermore, it allowed differentiating H5 anti-head-specific from cross-reacting anti-stalk antibodies, which represents a valuable feature with regard to the monitoring of future vaccination programs with H5-specific vaccines. Thus, the assay is a significant contribution to existing serological diagnostic tests for a clade-optimized and species-independent detection of influenza A virus antibodies.
Importance: The ongoing highly pathogenic avian influenza virus H5N1 panzootic has caused numerous outbreaks in domestic and wild animals, with frequent spillover events to unexpected host species, which underscores the importance of intensified surveillance. However, sensitive and specific multi-species serological assays represent a major gap. For this purpose, we developed a novel double-antigen enzyme-linked immunosorbent assay that employs an innovative luminescence-based readout strategy. The test allowed a highly sensitive and specific detection of H5-specific antibodies in a wide range of avian and mammalian species, including humans. It therefore represents a valuable contribution to improving species-independent serological diagnostic tools for the detection of influenza A virus antibodies.

Keywords: ELISA; H5 clade 2.3.4.4b; H5N1; HPAIV; antibodies; birds; highly pathogenic avian influenza virus; mammals; nanoluciferase; panzootic; serology; surveillance; wildlife.

 
Back
Top